Latest News

CTC and Mercodia enters a collaboration agreement

CTC Clinical Trial Consultants AB, based in Uppsala, and Mercodia also based in Uppsala are please to annonce that they have entered into a collaboration agreement.


Together the companies can offer their services in a combined package with both clinical services and high quality ELISAs in the areas of diabetes, obesity and cardiovascular disease.


CTC’s CEO, Anders Millerhovf, adds:

“Having a close collaboration with a high quality ELISA analysis lab can add substantial value to our clients. Early signals of clinical effect in early phase trials are crucial for many of our customers”


Mercodia , CEO, Mona Österberg, adds:

“We are very happy about this collaboration with the highly professional team at CTC, which is also a fellow Uppsala company. We believe that the combination of both companies’ core competences will increase the accuracy in the monitoring of clinical effects.


For more information CTC, please contact:
Anders Millerhovf – Chief Executive Officer
Telephone: +46 768 339 888



For more information Mercodia, please contact:

Name: Mona Österberg – Chief Executive Officer

Telephone: +46 18 570070




About CTC Clinical Trial Consultants AB

CTC is a Swedish full-service CRO with clinical conduct in focus. Our mission is to facilitate clinical and translational research by providing our customers cost-effective advice and implementation of early clinical trials (Phase 0 / I / IIa). CTC has two dedicated research clinics in Uppsala (12 hospital beds, 12 non-hospital beds) in combination with two patient clinics located both in Uppsala and Linköping. Read more at

About Mercodia AB

Mercodia is dedicated to advancing innovative therapies for the prevention and treatment of metabolic diseases by providing immunoassay technology for clinical and research applications. We service a global market of over 100 countries with immunoassays spanning nine different species, covering both the basic and clinical research sectors, as well as in vitro diagnostics. Mercodia also offers GLP-compliant outsourcing services for small, preclinical studies to larger PI-PII clinical studies. Our bioanalytical, development, and production services are guided by FDA/EMA and CLSI guidelines, our extensive quality system and ISO 13485 for manufacturing medical devices. We specialize in large molecule ligand-binding assays, PK/PD/TK analysis, and offer a unique expertise in life cycle management. Read more at

Back to all News